Literature DB >> 19058180

Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study.

Jocelyn S Kasper1, Yan Liu, Edward Giovannucci.   

Abstract

History of diabetes may be associated with decreased prostate cancer (PCa) risk. Published studies have not always accounted for time since diabetes diagnosis or confounding and effect modification by lifestyle factors. The authors investigated the relationship between diabetes and PCa risk in men in the Health Professionals Follow-Up Study from 1986 to 2004. During that time, 4,511 new PCa cases were identified. Multivariate hazard ratios (HR) were estimated using Cox regression. The HR of PCa comparing men with vs. without diabetes was 0.83 and 95% confidence interval (CI): 0.74, 0.94. PCa risk was not reduced in the first year after diabetes diagnosis (HR: 1.30, CI: 0.97, 1.72), was lower for men diagnosed for 1-6 years (HR: 0.82, CI: 0.66, 1.02), and was even lower for men who had been diagnosed for 6-15 (HR: 0.75, CI: 0.61, 0.93) or >15 years (HR: 0.78, CI: 0.63, 0.96). Reduced PCa risk was stronger in men diagnosed before 1994 (pre-PSA era) vs. after 1994. The authors also demonstrated that obese and diabetic men had a lower HR for PCa than those who were either not obese and diabetic or obese and non-diabetic. Results are consistent with the hypothesis that diabetes is associated with reduced PCa risk. Potential biological mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19058180      PMCID: PMC2680190          DOI: 10.1002/ijc.24044

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  52 in total

1.  Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.

Authors:  J Kellogg Parsons; H Ballentine Carter; Elizabeth A Platz; E James Wright; Patricia Landis; E Jeffrey Metter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-09       Impact factor: 4.254

2.  Diabetes mellitus and the risk of prostate cancer in Italy.

Authors:  A Tavani; S Gallus; M Bertuzzi; L Dal Maso; A Zucchetto; E Negri; S Franceschi; V Ramazzotti; M Montella; C La Vecchia
Journal:  Eur Urol       Date:  2005-01-06       Impact factor: 20.096

3.  Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland.

Authors:  J F Dorgan; D Albanes; J Virtamo; O P Heinonen; D W Chandler; M Galmarini; L M McShane; M J Barrett; J Tangrea; P R Taylor
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-12       Impact factor: 4.254

4.  Prostate cancer risk among men with diabetes mellitus (Spain).

Authors:  A González-Pérez; L A García Rodríguez
Journal:  Cancer Causes Control       Date:  2005-11       Impact factor: 2.506

5.  Diabetes mellitus and risk of prostate cancer (United States).

Authors:  E Giovannucci; E B Rimm; M J Stampfer; G A Colditz; W C Willett
Journal:  Cancer Causes Control       Date:  1998-01       Impact factor: 2.506

6.  Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women.

Authors:  F B Hu; J E Manson; S Liu; D Hunter; G A Colditz; K B Michels; F E Speizer; E Giovannucci
Journal:  J Natl Cancer Inst       Date:  1999-03-17       Impact factor: 13.506

7.  Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.

Authors:  Jan Hammarsten; Benkt Högstedt
Journal:  Eur J Cancer       Date:  2005-10-20       Impact factor: 9.162

8.  Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

Authors:  J M Chan; M J Stampfer; E Giovannucci; P H Gann; J Ma; P Wilkinson; C H Hennekens; M Pollak
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

9.  Diabetes and risk of prostate cancer in a prospective cohort of US men.

Authors:  Carmen Rodriguez; Alpa V Patel; Alison M Mondul; Eric J Jacobs; Michael J Thun; Eugenia E Calle
Journal:  Am J Epidemiol       Date:  2005-01-15       Impact factor: 4.897

10.  Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

Authors:  Elizabeth A Platz; Michael F Leitzmann; Nader Rifai; Philip W Kantoff; Yen-Ching Chen; Meir J Stampfer; Walter C Willett; Edward Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-05       Impact factor: 4.254

View more
  65 in total

1.  Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival.

Authors:  Erin L Richman; Stacey A Kenfield; Meir J Stampfer; Edward L Giovannucci; June M Chan
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-19

2.  The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study.

Authors:  Lauren P Wallner; Hal Morgenstern; Michaela E McGree; Debra J Jacobson; Jennifer L St Sauver; Steven J Jacobsen; Aruna V Sarma
Journal:  Urology       Date:  2010-11-20       Impact factor: 2.649

3.  Rare Coding Variants Associated with Breast Cancer.

Authors:  Mi-Ryung Han
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Prostate cancer risk in pre-diabetic men: a matched cohort study.

Authors:  Adedayo A Onitilo; Richard L Berg; Jessica M Engel; Rachel V Stankowski; Ingrid Glurich; Gail M Williams; Suhail A R Doi
Journal:  Clin Med Res       Date:  2013-05-08

5.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

6.  Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey.

Authors:  Steven L Chang; Lauren C Harshman; Joseph C Presti
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

Review 7.  Common medications and prostate cancer mortality: a review.

Authors:  Konrad H Stopsack; Alexandra J Greenberg; Lorelei A Mucci
Journal:  World J Urol       Date:  2016-08-04       Impact factor: 4.226

8.  The association between cancer and amyotrophic lateral sclerosis.

Authors:  D Michal Freedman; Rochelle E Curtis; Sarah E Daugherty; James J Goedert; Ralph W Kuncl; Margaret A Tucker
Journal:  Cancer Causes Control       Date:  2012-10-23       Impact factor: 2.506

9.  Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study.

Authors:  Jonathan L Wright; Janet L Stanford
Journal:  Cancer Causes Control       Date:  2009-08-04       Impact factor: 2.506

Review 10.  Genetics and the general physician: insights, applications and future challenges.

Authors:  J C Knight
Journal:  QJM       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.